In addition, studies have confirmed that the nuclear transcription factor NRF2 can inhibit the occurrence of ferroptosis in tumor cells by regulating the transcription of SLC7A11, and inhibiting the expression of NRF2 can enhance cell ferroptosis (60). Here, SLC7A11 is linked to neoplasm.